Cargando…
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report
BACKGROUND: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus −19 pandemic, clinicians raised concerns regarding continuation of antipsychotic treatment,...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840406/ https://www.ncbi.nlm.nih.gov/pubmed/33527097 http://dx.doi.org/10.1016/j.bbih.2021.100212 |